Drug Discovery & Pharmaceuticals

RSS
LGM Pharma invests $6 M in U.S. drug manufacturing capabilities for liquids, suspensions, semi-solids, and suppositories

LGM Pharma invests $6 M in U.S. drug manufacturing capabilities for liquids, suspensions, semi-solids, and suppositories

Shift Biosciences announces key appointments to advance rejuvenation therapeutics pipeline

Shift Biosciences announces key appointments to advance rejuvenation therapeutics pipeline

New automated system revolutionizes drug evaluation in zebrafish

New automated system revolutionizes drug evaluation in zebrafish

British scientists unveil world-leading technology to speed up drug discovery

British scientists unveil world-leading technology to speed up drug discovery

Vanderbilt researchers aim to use AI to develop antibody therapies for any target

Vanderbilt researchers aim to use AI to develop antibody therapies for any target

New drug VIP36 shows promise in treating pain without harmful side effects

New drug VIP36 shows promise in treating pain without harmful side effects

New chemical reaction enables precise functionalization of peptides and proteins

New chemical reaction enables precise functionalization of peptides and proteins

Microphysiological systems in drug discovery

Microphysiological systems in drug discovery

New antibody-toxin conjugate designed to stimulate immune-mediated eradication of tumors

New antibody-toxin conjugate designed to stimulate immune-mediated eradication of tumors

Insilico Medicine reaches preclinical milestone in MASH drug discovery

Insilico Medicine reaches preclinical milestone in MASH drug discovery

New antibiotic design could end the arms race with resistant bacteria

New antibiotic design could end the arms race with resistant bacteria

Breakthrough method opens door to fluorinated oxetane drug molecules

Breakthrough method opens door to fluorinated oxetane drug molecules

New computational tool iDOMO improves prediction of drug synergy

New computational tool iDOMO improves prediction of drug synergy

AI-driven discovery unveils TNIK inhibition as anti-aging strategy

AI-driven discovery unveils TNIK inhibition as anti-aging strategy

Harbour BioMed partners with Insilico to accelerate AI-powered antibody discovery

Harbour BioMed partners with Insilico to accelerate AI-powered antibody discovery

Zinc-carrying proteins may activate PPIs in the absence of gastric acid

Zinc-carrying proteins may activate PPIs in the absence of gastric acid

Breakthrough computational tool enhances design of targeted antiviral therapies

Breakthrough computational tool enhances design of targeted antiviral therapies

Insilico Medicine announces preclinical drug discovery benchmarks from 2021 to 2024

Insilico Medicine announces preclinical drug discovery benchmarks from 2021 to 2024

Innovative approach to synthesizing functional molecules with triple click chemistry

Innovative approach to synthesizing functional molecules with triple click chemistry

Insilico Medicine develops highly selective FGFR2/3 dual inhibitor for cancer treatment

Insilico Medicine develops highly selective FGFR2/3 dual inhibitor for cancer treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.